A Review on AQBD-Based RP-HPLC Method Development for Simultaneous Quantification of Domperidone and Naproxen Sodium in Pharmaceutical Dosage Forms

Authors

  • Vishal V Kendre Department of Pharmaceutical Quality Assurance, Dayanand Education Society’s Dayanand College of Pharmacy, Latur-4, Maharashtra, India.
  • Mahesh J Birajdar 2 Department of Pharmaceutical Chemistry, Dayanand Education Society’s, Dayanand College of Pharmacy, Latur- Maharashtra, India.
  • Dr. Balaji M Shetkar Department of Pharmaceutical Quality Assurance, Dayanand Education Society’s, Dayanand College of Pharmacy, Latur- Maharashtra, India.
  • Dr.Kranti L. Satpute Principal & HOD, Department of Pharmaceutical Quality Assurance, Dayanand Education Society’s, Dayanand College of Pharmacy, Latur-413512, Maharashtra, India.

Abstract

Analytical Quality by Design (AQbD) has recently become an important methodology used for developing robust analytical techniques.The present review aims at the development of a robust RP-HPLC method for the simultaneous quantitation of Domperidone and Naproxen sodium in the pharmaceutical dosage form utilizing the AQbD principles.Risk assessment tools were employed to identify critical method parameters (CMPs) and critical quality attributes (CQAs), which were then optimized using design of experiment (DoE).A number of chromatographic parameters, such as composition of mobile phase, flow rate, pH, and column choice, have been optimized in order to obtain the optimal resolution and precision.As compared to trial and error techniques, AQbD methodology provides enhanced method robustness and reliability.The developed RP-HPLC method was validated according to the international council for harmonization guidelines, and the specificity, linearity, accuracy, precision, and robustness were established for the simultaneous analysis of two drugs.

 

 

 

Downloads

Download data is not yet available.

References

Dhanagar ND, et al. Advancements in Solubility Enhancement Through Liquisolid Compact Technology: A Comprehensive Review. Res Rev J Drug Des Discov. 2024; 11(02): 25–34.

Lu M, et al. Liquisolid technique and its applications in pharmaceutics. Asian J Pharm Sci. 2017; 12(2): 115-123.

Spireas S, Bolton SM. Liquisolid systems and methods of preparing same. U.S. Patent No. 5,968,550. 1999.

Hussain Y, et al. The most recent advances in liquisolid technology: Perspectives in the pharmaceutical industry. Pharm Sci Adv. 2024; 2(1): 100038.

Khan A, et al. Liquisolid Technology: A State-of-the-Art Review on the Current State, Challenges, New and Emerging Technologies. Curr Drug Deliv. 2022; 17(9): 736-754.

Patil P, et al. Integrated QbD Approach for the Development of Liquisolid Compact of Apixaban for Improvement of Solubility and Dissolution Rate. Res J Pharm Tech. 2025; 18(5): 1-10.

Yadav PS, Hajare AA, Patil KS. Design and development of Fujicalin-based axitinib liquisolid compacts for improved dissolution and bioavailability. Eur J Pharm Biopharm. 2024; 204: 114506.

Chaudhari P, et al. Neusilin US2 based Liquisolid Compact technique for the enhancement of solubility and dissolution rate of Olmesartan. J Res Pharm. 2023; 27(1): 52-66.

Debbarma B, Sumer PDR. Solubility and Bioavailability Enhancement of a Novel Liquisolid Compact of Gliclazide. Uttar Pradesh J Zool. 2023; 44(22): 207-217.

Rubesh K, et al. Dissolution Enhancement of Lycopene Compacts by Liquisolid Technique. Int J App Pharm. 2025; 17(1): 45-53.

Lam M, et al. Liqui-pellet: the emerging next-generation oral dosage form which stems from liquisolid concept. AAPS PharmSciTech. 2020; 21(1): 1-15.

Published

2026-06-15

How to Cite

Vishal V Kendre, Mahesh J Birajdar, Dr. Balaji M Shetkar, & Dr.Kranti L. Satpute. (2026). A Review on AQBD-Based RP-HPLC Method Development for Simultaneous Quantification of Domperidone and Naproxen Sodium in Pharmaceutical Dosage Forms. Asian Journal of Pharmaceutical Research and Development, 14(3), 130–138. Retrieved from https://mail.ajprd.com/index.php/journal/article/view/1772

Issue

Vol. 14 No. 3 (2026): Volume 14 Issue 3 May - June 2026

Section

Review Articles

Copyright (c) 2026 Vishal V Kendre, Mahesh J Birajdar, Dr. Balaji M Shetkar, Dr.Kranti L. Satpute

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).